Compare Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund vs UTI Healthcare Fund
Risk
Very High
Very High
Rating
3.0
4.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.06
2.28
NAV
₹20.61
₹285.37
Fund Started
06 Oct 2020
01 Aug 2005
Fund Size
₹167.23 Cr
₹1055.53 Cr
Exit Load
-
Exit load of 1% if redeemed within 30 days.
1 Year
10.44%
6.50%
3 Year
19.20%
24.47%
5 Year
12.08%
14.00%
Equity
99.50%
98.67%
Cash
0.24%
1.32%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.73% |
Eli Lilly And Co | 5.72% |
Apollo Hospitals Enterprise Ltd. | 5.59% |
Max Healthcare Institute Ltd. | 5.30% |
Divi's Laboratories Ltd. | 5.08% |
Cipla Ltd. | 4.84% |
Dr. Reddy's Laboratories Ltd. | 4.76% |
Johnson & Johnson Ltd. | 4.52% |
Lupin Ltd. | 4.13% |
Torrent Pharmaceuticals Ltd. | 3.55% |
Sun Pharmaceutical Industries Ltd. | 9.99% |
Ajanta Pharma Ltd. | 6.40% |
Lupin Ltd. | 5.92% |
Glenmark Pharmaceuticals Ltd. | 4.04% |
Apollo Hospitals Enterprise Ltd. | 3.73% |
Gland Pharma Ltd. | 3.46% |
Dr. Reddy's Laboratories Ltd. | 3.45% |
Divi's Laboratories Ltd. | 3.42% |
Alkem Laboratories Ltd. | 3.41% |
Fortis Healthcare Ltd. | 3.01% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors.
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
06 Oct 2020
01 Aug 2005
